{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:55:58Z","timestamp":1781510158833,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.msard.2025.106926","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:17:19Z","timestamp":1765423039000},"page":"106926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case series"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0767-2072","authenticated-orcid":false,"given":"Lucas P.","family":"Garfinkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Stankevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Penckofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathi","family":"Sajeendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Santos","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Thon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga R.","family":"Thon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106926_bib0001","doi-asserted-by":"crossref","first-page":"143","DOI":"10.12659\/AJCR.900563","article-title":"Rituximab can induce remission in a patient with ankylosing spondylitis who failed anti-TNF-\u03b1 agent","volume":"18","author":"AlDhaheri","year":"2017","journal-title":"Am. J. Case. Rep"},{"issue":"11","key":"10.1016\/j.msard.2025.106926_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(06)70552-X","article-title":"Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study","volume":"5","author":"Barcellos","year":"2006","journal-title":"Lancet. Neurol"},{"key":"10.1016\/j.msard.2025.106926_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103963","article-title":"Ocrelizumab during pregnancy and lactation: rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants","volume":"64","author":"Bove","year":"2022","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2025.106926_bib0004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/ard.48.12.971","article-title":"Is there an association between ankylosing spondylitis and multiple sclerosis?","volume":"48","author":"Calin","year":"1989","journal-title":"Ann. Rheum. Dis"},{"issue":"12","key":"10.1016\/j.msard.2025.106926_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s002340100619","article-title":"Cerebral magnetic resonance imaging in a patient with ankylosing spondylitis and multiple sclerosis-like syndrome","volume":"43","author":"Cellerini","year":"2001","journal-title":"Neuroradiology"},{"issue":"6","key":"10.1016\/j.msard.2025.106926_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00296-025-05902-7","article-title":"Safety and efficacy of IL-17 inhibitors in patients with comorbid multiple sclerosis\/multiple Sclerosis-like syndrome: a systematic review","volume":"45","author":"Chaitidis","year":"2025","journal-title":"Rheumatol. Int"},{"issue":"1","key":"10.1016\/j.msard.2025.106926_bib0007","article-title":"Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis","volume":"8","author":"Chey","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin"},{"issue":"5","key":"10.1016\/j.msard.2025.106926_bib0008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"Confavreux","year":"1998","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.msard.2025.106926_bib0009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Consortium","year":"2007","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.msard.2025.106926_bib0010","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1212\/NXI.0000000000000117","article-title":"Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis","volume":"2","author":"Constantinescu","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"11","key":"10.1016\/j.msard.2025.106926_bib0011","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrneurol.2010.147","article-title":"Multiple sclerosis: autoimmune associations in multiple sclerosis","volume":"6","author":"Constantinescu","year":"2010","journal-title":"Nat. Rev. Neurol"},{"key":"10.1016\/j.msard.2025.106926_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.msard.2019.08.006","article-title":"Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: report of two clinical cases","volume":"35","author":"Cortese","year":"2019","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2025.106926_bib0013","doi-asserted-by":"crossref","unstructured":"Cox J.G., Cole J.H., Kempton M.J., Williams S.C.R., de Groot M. Volume and distribution of white matter hyperintensities in rheumatoid arthritis and ulcerative colitis patients. medRxiv. Preprint posted online May 31, 2024. doi:10.1101\/2024.05.30.24308189.","DOI":"10.1101\/2024.05.30.24308189"},{"key":"10.1016\/j.msard.2025.106926_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2024.09.002","article-title":"TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease","volume":"123","author":"Desu","year":"2025","journal-title":"Brain. Behav. Immun"},{"issue":"1","key":"10.1016\/j.msard.2025.106926_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/pn-2022-003426","article-title":"Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines","volume":"23","author":"Dobson","year":"2023","journal-title":"Pr. Neurol"},{"issue":"25","key":"10.1016\/j.msard.2025.106926_bib0016","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.msard.2025.106926_bib0017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"Edwards","year":"2004","journal-title":"Mult. Scler"},{"issue":"6","key":"10.1016\/j.msard.2025.106926_bib0018","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2217\/imt-2021-0128","article-title":"Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review","volume":"14","author":"Eksin","year":"2022","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.msard.2025.106926_bib0019","first-page":"98","article-title":"The prevalence of autoimmune diseases in patients with multiple sclerosis: a cross-sectional study in Qom, Iran, in 2018","volume":"19","author":"Ershadinia","year":"2020","journal-title":"Curr. J. Neurol"},{"key":"10.1016\/j.msard.2025.106926_bib0020","first-page":"465","article-title":"Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia","volume":"22","author":"Fernandez-Sueiro","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.msard.2025.106926_bib0021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet. Neurol"},{"key":"10.1016\/j.msard.2025.106926_bib0022","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jocn.2017.06.031","article-title":"Coexistence of multiple sclerosis and ankylosing spondylitis: report of four cases from Russia and review of the literature","volume":"44","author":"Fominykh","year":"2017","journal-title":"J. Clin. Neurosci"},{"issue":"1","key":"10.1016\/j.msard.2025.106926_bib0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.55563\/clinexprheumatol\/rl668e","article-title":"Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary","volume":"39","author":"Fonti","year":"2021","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1016\/j.msard.2025.106926_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13075-019-1877-z","article-title":"Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters","volume":"21","author":"Gamal","year":"2019","journal-title":"Arthritis. Res. Ther."},{"issue":"4","key":"10.1016\/j.msard.2025.106926_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/imm.13198","article-title":"The role of B cells in the immunopathogenesis of multiple sclerosis","volume":"160","author":"Gharibi","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2025.106926_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103792","article-title":"Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: a descriptive analysis of real-world data","volume":"62","author":"Gitman","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106926_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213448","article-title":"Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders","volume":"14","author":"Gonzalez Caldito","year":"2023","journal-title":"Front. Immunol"},{"issue":"7412","key":"10.1016\/j.msard.2025.106926_bib0028","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.msard.2025.106926_bib0029","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/CM9.0000000000002074","article-title":"Features of hyperintense white matter lesions and clinical relevance in systemic lupus erythematosus","volume":"135","author":"Guo","year":"2022","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.msard.2025.106926_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.rdc.2017.04.006","article-title":"Genetics and the causes of ankylosing spondylitis","volume":"43","author":"Hanson","year":"2017","journal-title":"Rheum. Dis. Clin. North. Am"},{"key":"10.1016\/j.msard.2025.106926_bib0031","first-page":"S26","article-title":"The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities","volume":"27","author":"Inman","year":"2009","journal-title":"Clin. Exp. Rheumatol"},{"issue":"7","key":"10.1016\/j.msard.2025.106926_bib0032","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780220716","article-title":"Ankylosing spondylitis and multiple sclerosis: a possible association","volume":"22","author":"Khan","year":"1979","journal-title":"Arthritis. Rheum"},{"issue":"8","key":"10.1016\/j.msard.2025.106926_bib0033","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaneurol.2020.1162","article-title":"Association between tumor necrosis factor inhibitor exposure and inflammatory Central nervous system events","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA. Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106926_bib0034","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4049\/jimmunol.1600138","article-title":"IL-17 promotes neutrophil-mediated immunity by activating microvascular pericytes and not endothelium","volume":"197","author":"Liu","year":"2016","journal-title":"J. Immunol"},{"issue":"3\u20134","key":"10.1016\/j.msard.2025.106926_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000351248","article-title":"Coexistence of multiple sclerosis and ankylosing spondylitis: report of two cases","volume":"70","author":"Lourbopoulos","year":"2013","journal-title":"Eur. Neurol"},{"issue":"2","key":"10.1016\/j.msard.2025.106926_bib0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann. Rheum. Dis"},{"issue":"4","key":"10.1016\/j.msard.2025.106926_bib0037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10072-009-0092-0","article-title":"Occurrence of ankylosing spondylitis and multiple sclerosis-like syndrome in a HLA-B27 positive patient","volume":"30","author":"Mignarri","year":"2009","journal-title":"Neurol. Sci"},{"key":"10.1016\/j.msard.2025.106926_bib0038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biologicals.2019.06.002","article-title":"Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis - A novel approach","volume":"60","author":"Nisar","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.msard.2025.106926_bib0039","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"15","key":"10.1016\/j.msard.2025.106926_bib0040","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.3390\/jcm14155181","article-title":"Evaluating Secukinumab as treatment for axial spondyloarthritis and psoriatic arthritis in patients with comorbidities: multicenter real-life experience","volume":"14","author":"Ocak","year":"2025","journal-title":"J. Clin. Med"},{"issue":"8","key":"10.1016\/j.msard.2025.106926_bib0041","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10067-012-2002-8","article-title":"Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature","volume":"31","author":"Omair","year":"2012","journal-title":"Clin. Rheumatol"},{"issue":"8","key":"10.1016\/j.msard.2025.106926_bib0042","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00296-006-0282-5","article-title":"Multiple sclerosis associated with systemic sclerosis","volume":"27","author":"Pelidou","year":"2007","journal-title":"Rheumatol. Int"},{"issue":"5","key":"10.1016\/j.msard.2025.106926_bib0043","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/AOG.0000000000003755","article-title":"Rheumatologic medication use during pregnancy","volume":"135","author":"Peterson","year":"2020","journal-title":"Obs. Gynecol"},{"issue":"5","key":"10.1016\/j.msard.2025.106926_bib0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/03009740802136164","article-title":"Multiple sclerosis following etanercept treatment for ankylosing spondylitis","volume":"37","author":"Pfueller","year":"2008","journal-title":"Scand. J. Rheumatol"},{"key":"10.1016\/j.msard.2025.106926_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.msard.2025.106926_bib0047","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.msard.2025.106926_bib0048","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/art.33317","article-title":"Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial","volume":"64","author":"Rigby","year":"2012","journal-title":"Arthritis. Rheum"},{"key":"10.1016\/j.msard.2025.106926_bib0049","series-title":"White Matter Lesions","author":"Sharma","year":"2025"},{"issue":"26","key":"10.1016\/j.msard.2025.106926_bib0050","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.msard.2025.106926_bib0051","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/key047","article-title":"Disease activity during and after pregnancy in women with axial spondylarthritis: a prospective multicentre study","volume":"57","author":"Ursin","year":"2018","journal-title":"Rheumatol. (Oxf.)"},{"key":"10.1016\/j.msard.2025.106926_bib0052","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00296-012-2625-8","article-title":"Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis","volume":"34","author":"Uyguno\u011flu","year":"2014","journal-title":"Rheumatol. Int"},{"issue":"1","key":"10.1016\/j.msard.2025.106926_bib0053","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200349","article-title":"Pregnancy and infant outcomes in women with multiple sclerosis treated with ocrelizumab","volume":"12","author":"Vukusic","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"4","key":"10.1016\/j.msard.2025.106926_bib0054","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/PJNNS.a2023.0038","article-title":"Multiple sclerosis and autoimmune diseases\u2014a case control study","volume":"57","author":"Wawrzyniak","year":"2023","journal-title":"Neurol. Neurochir. Pol"},{"issue":"24","key":"10.1016\/j.msard.2025.106926_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413325","article-title":"B cell involvement in the pathogenesis of ankylosing spondylitis","volume":"22","author":"Wilbrink","year":"2021","journal-title":"Int. J. Mol. Sci"},{"issue":"8","key":"10.1016\/j.msard.2025.106926_bib0056","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2665-9913(24)00099-7","article-title":"Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"6","author":"Worth","year":"2024","journal-title":"Lancet. Rheumatol"},{"issue":"6","key":"10.1016\/j.msard.2025.106926_bib0057","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200328","article-title":"Disease activity in pregnant and postpartum women with multiple sclerosis receiving Ocrelizumab or other Disease-modifying therapies","volume":"11","author":"Yeh","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"4","key":"10.1016\/j.msard.2025.106926_bib0058","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4103\/neuroindia.NI_371_20","article-title":"Progressive demyelinating disease associated with Adalimumab treatment in a patient diagnosed with ankylosing spondylitis","volume":"73","author":"Yetkin","year":"2025","journal-title":"Neurol. India"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:47:49Z","timestamp":1781509669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S2211034825006649"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106926","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case series","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106926"}}